Pharvaris (PHVS) Total Liabilities (2019 - 2026)

Pharvaris (PHVS) has 8 years of Total Liabilities data on file, last reported at $27.5 million in Q1 2026.

• Quarterly Total Liabilities rose 14.88% year-over-year to $27.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.5 million (up 14.88% YoY) and the FY2025 annual result came in at $34.1 million, up 33.41% from the prior year.
• Total Liabilities retreated to $27.5 million in Q1 2026, from $35.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $35.1 million in Q4 2025 to a low of $11.5 million in Q1 2022.
• A 5-year average of $21.6 million and a median of $20.0 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities jumped 130.85% — and 2023, when it decreased 16.39%.
• Tracing PHVS's Total Liabilities over 5 years: stood at $18.8 million in 2022, then slipped by 16.39% to $15.8 million in 2023, then jumped by 60.13% to $25.2 million in 2024, then surged by 39.22% to $35.1 million in 2025, then fell by 21.84% to $27.5 million in 2026.
• The last three Total Liabilities figures came in at $27.5 million (Q1 2026), $35.1 million (Q4 2025), and $31.2 million (Q3 2025), per Business Quant data.